{"filings":[{"id":2522196,"accession_number":"0002014596-26-000060","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-08-27T20:50:10+00:00","items":["1.01","9.01"],"status":"ready","headline":"Concentra repurchases 1M shares from Chairman at $34.65/share for $34.65M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Repurchased 1,000,000 shares from Chairman Robert A. Ortenzio and related trusts at $34.65/share, total $34.65M.","Purchase price is 1% discount to Aug 21, 2026 closing price; funded from cash on hand.","Shares represent ~0.784% of outstanding common stock; under existing buyback program.","Related-party transaction approved by independent Audit and Compliance Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2107518,"accession_number":"0002014596-26-000055","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-08-06T20:49:49+00:00","items":["2.02","5.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentra Q2 revenue up 10%, net income up 46%; raises FY guidance; CEO succession to DiCanio","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $606M (+10% YoY), net income $67.3M (+45.7%), adjusted EBITDA $140.9M (+22.5%).","Raised FY 2026 guidance: revenue $2.325B-$2.375B, adjusted EBITDA $485M-$495M.","CEO Keith Newton to become Executive Chairman; President/CFO Matt DiCanio to become CEO effective Nov 1, 2026.","Declared $0.0625/share dividend, payable Aug 28, record Aug 20.","Repurchased 0.4M shares for $11M; net leverage 2.99x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1582476,"accession_number":"0002014596-26-000047","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-07-10T20:53:08+00:00","items":["5.02","9.01"],"status":"ready","headline":"Concentra CMO Dr. John Anderson to retire; enters consulting agreement with equity vesting terms","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. John R. Anderson, EVP and CMO, retires Dec 31, 2026; consulting agreement Jan 1-Dec 31, 2027.","Consulting fee $216/hour for up to 10 hours/week; unvested restricted stock continues to vest during term.","If consultant completes full term, 25% of then-unvested restricted stock automatically vests; forfeiture for cause or resignation.","Outstanding unvested restricted stock: 105,000 shares from 2024 and 2025 grants with vesting through 2029.","Consulting agreement includes non-compete, non-solicitation, confidentiality obligations extended 12 months post-term."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97211,"accession_number":"0002014596-26-000042","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentra Q1 revenue $569.6M (+13.7%); raises FY26 guidance; declares $0.0625 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $569.6M (+13.7% YoY); net income $52.3M (+28.7%); EPS $0.39, adjusted EPS $0.40.","Patient visits 3.4M (54,271/day, +6.7%); revenue per visit $151.47 (+3.1%).","Adjusted EBITDA $120.7M (+17.6%); Free Cash Flow $9.9M vs -$4.0M prior year.","Raised FY26 guidance: revenue $2.275B-$2.375B, Adj. EBITDA $460M-$480M, FCF $215M-$235M.","Declared $0.0625/share dividend, payable June 9; repurchased ~0.7M shares for $15M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":569555000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97210,"accession_number":"0001104659-26-052886","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Concentra stockholders elect directors, approve say-on-pay and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Vipin Gopal, William K. Newton, and Dr. Marc R. Watkins as Class II directors with 98%+ 'For' votes (excluding broker non-votes).","Non-binding advisory vote on named executive officer compensation approved: 114,180,227 For (95.7% of votes cast).","Ratification of PricewaterhouseCoopers as independent auditor for FY 2026 approved: 121,568,869 For (99.7% of votes cast).","All proposals pass; broker non-votes of 2,527,251 on director and say-on-pay proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97209,"accession_number":"0001104659-26-043229","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-04-14T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Concentra CMO Dr. John Anderson to retire Dec 31, 2026; consulting role planned","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. John Anderson, EVP and Chief Medical Officer, will retire effective December 31, 2026.","He will enter a consulting agreement to support the transition after his retirement.","Concentra has initiated a formal search for Anderson’s successor.","Anderson joined Concentra in 1993 and served as CMO since 2014."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111800,"accession_number":"0002014596-26-000027","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentra Q4 revenue +15.9% to $539M; guides FY2026 rev $2.25B-$2.35B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 net income $36.2M (+58.7% YoY); EPS $0.27, adjusted EPS $0.28.","FY2025 revenue $2,163.4M (+13.9%); adjusted EBITDA $431.9M (+14.6%).","Occupational health centers grew to 628 (from 552); onsite clinics 411 (from 157).","Board declared $0.0625/share dividend, payable March 19, 2026.","FY2026 outlook: rev $2.25B-$2.35B, adj. EBITDA $450M-$470M, FCF $200M-$225M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":2163417000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111799,"accession_number":"0002014596-26-000015","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-01-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Concentra beats 2025 guidance; Q4 revenue +15.9% to $539M, FY revenue +13.9% to $2.16B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $539.1M (+15.9%), net income $36.2M (+58.7%), adjusted EBITDA $95.3M (+22.9%).","Full year 2025 revenue $2,163.4M (+13.9%), adjusted EBITDA $431.9M (+14.6%), EPS $1.30 (adj $1.37).","2026 guidance: revenue $2.25-2.35B, adjusted EBITDA $450-470M, free cash flow $200-225M.","Added 300+ locations in 2025; total occupational health centers 628, onsite clinics 411.","Repurchased ~1.1M shares for $22.4M in Q4; net leverage 3.4x, targeting ≤3.0x in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":1.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":2163417000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111798,"accession_number":"0002014596-26-000009","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Concentra releases preliminary Q4 2025 operational metrics; details not provided in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company published a presentation with preliminary unaudited Q4 2025 operational metrics.","Presentation to be delivered at J.P. Morgan Healthcare Conference on Jan 14, 2026.","Recording of the presentation will be posted on the company's investor relations website.","Filing does not disclose any specific financial figures; confidence in metrics is low."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":128421,"accession_number":"0002014596-25-000049","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Concentra grants 645,000 restricted shares to six named executive officers; vest over four years","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO W. Keith Newton received 225,000 restricted shares; CFO Matthew T. DiCanio received 180,000 shares.","Four other executives (deLorimier, Anderson, Kosuth, Nelson) each received 60,000 restricted shares.","Grants made under the 2024 Equity Incentive Plan on November 4, 2025.","Shares vest in equal annual installments over four years from grant date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":128420,"accession_number":"0002014596-25-000045","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentra Q3 revenue +17% to $572.8M, EPS $0.38, raises FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $572.8M (+17% YoY); net income $49.8M; EPS $0.38; adjusted EPS $0.39.","Adjusted EBITDA $118.9M (+17.1% YoY); visits per day +9.2%; revenue per visit $147.31 (+4.2%).","FY2025 guidance raised: revenue $2.145-2.160B, Adj. EBITDA $425-430M; net leverage target ≤3.5x.","Board declares $0.0625/share dividend payable Dec 9, 2025; authorizes $100M share repurchase program through Dec 2027.","Year-to-date revenue $1.624B (+13.2%); Adj. EBITDA $336.6M (+12.5%); total centers 628, onsite clinics 413."],"consensus_eps_estimate":null,"consensus_eps_actual":1.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":1624337000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145216,"accession_number":"0002014596-25-000034","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentra Q2 revenue $550.8M (+15.2%), raises FY 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $550.8M (+15.2% YoY), net income $46.2M, EPS $0.35, adjusted EPS $0.37.","Adjusted EBITDA $115.0M (+13.2% YoY); raised FY 2025 guidance: revenue $2.13-2.16B, Adj EBITDA $420-430M.","Declared cash dividend $0.0625/share, payable Aug 28, record Aug 21.","Closed acquisition of Pivot Onsite Innovations for $54.4M, adding 240+ onsite clinics.","Patient visits per day +9.5% YoY; revenue per visit +4.4% to $145.92."],"consensus_eps_estimate":null,"consensus_eps_actual":0.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":1051537000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163639,"accession_number":"0001104659-25-063070","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-06-26T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Concentra appoints Vipin Gopal and Brigid Bonner to board, effective July 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Vipin Gopal and Brigid Bonner appointed to Concentra board, effective July 1, 2025.","Board expands to seven members with the two new appointments.","Gopal brings expertise in data, AI, and digital transformation from Eli Lilly, Walgreens, Humana.","Bonner brings strategic planning and digital transformation experience from UnitedHealth Group, IBM, Target.","CEO cites opportunity to increase shareholder value with new board expertise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163638,"accession_number":"0001104659-25-055287","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["2.01","7.01","9.01"],"status":"ready","headline":"Concentra closes $55M acquisition of Pivot Onsite Innovations, doubling onsite clinics to ~350","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all equity of Onsite Innovations (Pivot Onsite) for $55M, using cash and revolver.","Onsite Innovations operates ~200 clinics; combined Concentra Onsite Health now ~350 clinics across 40+ states.","Key leaders Dr. Lawrence Goren, Scott Goren, and Paul Goren transition to Concentra Onsite Health.","Acquisition financed with cash on hand and available revolver borrowing.","Deal doubles size of Concentra Onsite Health segment, aligning with growth strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163637,"accession_number":"0002014596-25-000021","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentra Q1 revenue $500.8M (+7.1% YoY), Adj. EBITDA $102.7M (+6.8%), raises 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $40.6M ($0.30 EPS); adjusted EPS $0.32, down from $0.49 YoY due to higher interest from IPO recap.","Closed $265M Nova Medical Centers acquisition (67 centers); signed $55M deal for Pivot Onsite Innovations (~200 clinics).","Declared $0.0625/share cash dividend, payable May 29; record date May 20.","FY2025 guidance raised: revenue $2.1-2.15B, Adj. EBITDA $415-430M; net leverage target ~3.5x.","Patient visits per day up 3.2% YoY; total centers 627 (vs 547 a year ago)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":500752000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163636,"accession_number":"0001104659-25-044127","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Concentra shareholders elect two Class I directors and approve say-on-pay at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Daniel J. Thomas elected with 112,356,457 votes for; Cheryl B. Pegus elected with 113,994,041 votes for.","Advisory vote on executive compensation approved with 92,051,122 for, 25,350,156 against.","Shareholders selected 1 year as frequency for future advisory votes on exec comp (113,659,054 for 1 year).","Ratification of PricewaterhouseCoopers as auditor for FY2025 approved with 122,300,023 for, 291,151 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163635,"accession_number":"0001104659-25-036598","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-04-21T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Concentra to acquire Pivot Onsite Innovations for $55M; doubles onsite health segment","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["$55M acquisition of Pivot Onsite Innovations from Athletico Physical Therapy.","Concentra Onsite Health expands from ~150 to ~350 clinics across 40+ states.","Transaction expected to close in Q2 2025, financed with cash on hand and revolver.","Key Pivot executives (Dr. Lawrence Goren, Scott Goren, Paul Goren) to join Concentra."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181545,"accession_number":"0002014596-25-000009","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["1.01","2.01","2.02","2.03","8.01","9.01"],"status":"ready","headline":"Concentra Q4 revenue +5.5% to $465M, adjusted EBITDA +13.6%; closes $265M Nova acquisition; declares $0.0625 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $465.0M (+5.5% YoY); net income $22.8M ($0.17 EPS).","FY2024 revenue $1,900.2M (+3.4% YoY); adjusted EBITDA $376.9M (+4.3% YoY).","Closed acquisition of Nova Medical Centers for $265M; adds 67 centers across 5 states.","2025 guidance: revenue ~$2.1B, adjusted EBITDA $410-425M; targeting net leverage ~3.0x in 18-24 months.","Declared quarterly dividend $0.0625/share, payable April 1 to March 18 record date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181544,"accession_number":"0001104659-25-005359","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-01-23T23:59:59+00:00","items":["1.01","2.02","9.01"],"status":"ready","headline":"Concentra to acquire Nova Medical Centers for $265M; Q4 revenue $465M (+5.5% YoY)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Agreement to buy all membership interests of Nova Medical Centers for $265M; expected close in Q1 2025.","Q4 2024 revenue $465.0M (+5.5% YoY); net income $20.6-22.6M vs $28.9M in Q4 2023.","Adjusted EBITDA Q4 $77.5M (+13.6% YoY); full-year 2024 Adj. EBITDA $376.9M (+4.3% YoY).","Patient visits per day declined 2.1% in Q4; revenue per visit up 5.8% to $145.08.","2025 guidance: revenue ~$2.1B; Adj. EBITDA $410-425M; capex $80-90M; net leverage ~3.5x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181543,"accession_number":"0001104659-25-003747","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2025-01-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Concentra approves 2025 base salaries for named executive officers","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO William K. Newton 2025 base salary set at $850,000.","President and CFO Matthew T. DiCanio salary approved at $575,000.","Other executives: deLorimier $450k, Nelson $400k, Gallara $400k.","Officers also eligible for 2025 Executive Leadership Team incentive plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198317,"accession_number":"0001104659-24-124122","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2024-11-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Concentra grants 585K restricted shares to 5 named executive officers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO W. Keith Newton receives 225,000 shares; vests equally over 4 years.","CFO Matthew T. DiCanio receives 180,000 shares; same 4-year ratable vest.","COO John A. deLorimier, CIO Giovanni Gallara, CAO Su Zan Nelson each get 60,000 shares.","Grants awarded under 2024 Equity Incentive Plan; effective date November 26, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198316,"accession_number":"0001104659-24-123175","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2024-11-26T23:59:59+00:00","items":["5.01","9.01"],"status":"ready","headline":"Concentra completes spin-off from Select Medical; distributes 104M shares to Select stockholders","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Select Medical distributed 104,093,503 shares of Concentra common stock (81.7% ownership) to its stockholders.","Select Medical stockholders received 0.806971 shares of Concentra for each Select Medical share held as of Nov 18 record date.","No fractional shares issued; cash will be paid in lieu of fractional shares.","After distribution, Select Medical no longer owns any Concentra shares; Concentra now independently traded."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198315,"accession_number":"0001104659-24-116513","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Concentra furnishes investor presentation; content not disclosed in filing text","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Regulation FD disclosure of a presentation for Q4 2024 investor discussions.","Presentation content is not included in the provided filing text; no specific facts available.","Filing is procedural, furnishing Exhibit 99.1 without substantive financial or operational details."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198314,"accession_number":"0001104659-24-113097","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Concentra Q3 revenue $489.6M (+3.3%); Adj. EBITDA $101.6M; declares $0.0625 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $45.8M, EPS $0.37; Adjusted EBITDA margin 20.7% vs 20.9% YoY.","Revenue per visit up 3.9% to $141.42; patient visits per day down 2.2%.","Cash $136.8M, total debt $1,482.3M, net leverage 3.7x.","FY 2024 guidance: revenue ~$1.9B, Adj. EBITDA $370-375M, capex $65-70M.","Dividend of $0.0625/share payable Nov 22 to record Nov 13."],"consensus_eps_estimate":null,"consensus_eps_actual":1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":1435151000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":198313,"accession_number":"0001104659-24-112675","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Concentra amends CFO DiCanio's employment: salary to $550K, severance extended to 18 months","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Base salary increased to $550,000, effective January 1, 2024.","Severance term extended from 9 to 18 months; eligible after change of control.","Title confirmed as President & CFO of Concentra and parent company.","Eligible for annual performance bonus and equity awards under 2024 Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214429,"accession_number":"0001104659-24-084962","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Concentra Q2 revenue up 2.3% to $477.9M; completed IPO on July 26","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $53.1M (-1.8% YoY); EPS $0.50 (-2.0% YoY); Adjusted EPS $0.49.","Adjusted EBITDA $101.6M (+1.2% YoY); margin 21.3% vs 21.5% YoY.","Revenue per visit $139.81 (+3.9% YoY); patient visits down 1.6% to 3.214M.","IPO of 22.5M shares at $23.50 for $528.8M gross; stock trades NYSE under CON.","New debt: $650M 6.875% Senior Notes due 2032; $850M Term Loan; $400M revolver."],"consensus_eps_estimate":null,"consensus_eps_actual":0.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":945513000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214428,"accession_number":"0001104659-24-084490","cik":2014596,"company_name":"Concentra Group Holdings Parent, Inc.","ticker":"CON","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["1.01","2.03","5.02","5.03","9.01"],"status":"ready","headline":"Concentra completes IPO, enters $1.25B credit facility and issues $650M notes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed IPO of 22.5M shares at $23.50/share, net proceeds ~$499.7M.","Net proceeds used to repay intercompany debt to parent Select Medical.","Entered $1.25B senior secured credit facilities ($850M term loan, $400M revolver).","Issued $650M 6.875% senior notes due 2032; assumed by CHSI after merger.","Appointed Drs. Cheryl Pegus and Marc R. Watkins to board effective July 26, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3271342920.563372,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}